Skip to main content

Published locations for FDA expands indication for pembrolizumab in NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA expands indication for pembrolizumab in NSCLC

User login

  • Reset your password
  • /content/fda-expands-indication-pembrolizumab-nsclc
  • /oncologypractice/article/116356/lung-cancer/fda-expands-indication-pembrolizumab-nsclc
  • /node/155702/article/116356/lung-cancer/fda-expands-indication-pembrolizumab-nsclc
  • /hematology-oncology/article/116356/lung-cancer/fda-expands-indication-pembrolizumab-nsclc
  • /chestphysician/article/116356/lung-cancer/fda-expands-indication-pembrolizumab-nsclc